Skip to main content

Table 2 Summary of study characteristics and costs per DALY averted for interventions targeting pregnant women

From: Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review

References Publication year Country/region Malaria intervention Main data sources Life tables source Cost-effectiveness threshold used Cost-effectiveness ratio
(cost per DALY averted)
DALYs averted per $ 1 million spent on intervention
[1] 1999 Sub-Saharan Africa ITNs, residual spraying, chemoprophylaxis and improved malaria treatment Published and unpublished sources
Programmes
GBD study US$ 30–US$ 150 $4–$10 for treatment of existing nets 142,857
$19–$85 for residual spraying 19,231
$3–$12 chemoprophylaxis for children 133,333
$4–$29 for pregnant women treatment 58,997
$1–$8 for case management 222,222
[2] 2001 Non-specific Sulfadoxine–pyrimethamine Published and unpublished data Kenyan life table Not stated $10–14 83,333
[3] 2009 DRC Insecticide treated nets (ITNs) distribution Clinic records, program records and peer-reviewed literature WHO life table 1–3 times GDP per capita $17.22 58,072
[4] 2010 Mozambique Intermittent preventive treatment Demographic surveillance system Mozambique life table US$ 36–US$ 129 $41.46 (maternal malaria) 24,120
[5] 2015 Model Intermittent preventive treatment Published data GBD (2010 and 2004) 1–3 times GDP per capita $7.28 137,363
[6] 2015 Multi-country Intermittent preventive treatment Clinical trials
Published data
Country-specific US$ 240 $136.30 7337